688266.SS

Suzhou Zelgen Biopharmaceuticals Co., Ltd.

HealthcareBiotechnologyCNCNYPeers →Country macro →

$89.69

+3.17%Jun 18, 2026

AI Brief

Market cap

$23.98B

52w range

—

P / E

—

EPS

—

Volume

—

Revenue · FY

—

Overview Fundamentals Market Narrative & AI

Explain this page

Arphra AIPlain-English read on Suzhou Zelgen Biopharmaceuticals Co., Ltd.’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$89.69

Change

-21.09%

Period high

$133.48

Period low

$75.75

Period start

$113.662025-06-23

Through 2026-06-18

Fair value

Football field →

Weighted blend

—

— vs spot

Recommendation

n/a

0 of 0 methods

Method spread

0bull0bear

±5% threshold

Candlestick · 1Y

Open in chart workstation →

688266.SS

89.69-21.09%

H 134.17L 75.10MA50 98.24MA200 98.46Avg vol 3.6M

Insider · 30d

History →

Bought

0 txns

Sold

0 txns

Net flow

+$0

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Sector & industry today

Live

Sectors

Real Estate
+1.26%
Industrials
+1.00%
Basic Materials
+0.65%
Energy
+0.59%
Healthcare
+0.01%
Utilities
-0.07%
Financial Services
-0.24%
Communication Services
-0.55%
Technology
-0.80%
Consumer Cyclical
-0.85%
Consumer Defensive
-1.00%

Top industries (issuer's industry highlighted)

Biotechnology
+6.56%
Financial - Mortgages
-4.05%
Electrical Equipment & Parts
+3.88%
Staffing & Employment Services
-3.62%
Software - Services
-3.30%
Software - Infrastructure
-3.07%
Advertising Agencies
+2.92%
Apparel - Footwear & Accessories
-2.80%
Engineering & Construction
+2.80%
Financial - Conglomerates
+2.62%
Luxury Goods
+2.47%
Hardware, Equipment & Parts
+2.34%

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

No recent news for 688266.SS.

Financial scores

DBJun 23, 2026

Altman Z

7.92

Safe

≥ 3.0 safe · 1.81–3.0 grey · < 1.81 distress

Piotroski F

7/9

Strong

≥ 7 strong · 4–6 average · < 4 weak

Peers

No peer list available for 688266.SS.

Total assets

—

Total debt

—

Cash & equiv

—

Operating CF

—

Free cash flow

—

Buybacks

—

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin